Genes involved in radiation therapy response in head and neck cancers

Laryngoscope

Volumn 119, Issue 1, 2009, Pages 91-101

  Dumur, Catherine I ^a   Ladd, Amy C ^a   Wright, Harry V ^a   Penberthy, Lynne T ^a   Wilkinson, David S ^a   Powers, Celeste N ^a   Garrett, Carleton T ^a   DiNardo, Laurence J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Chemoradiation response; Head and neck cancer; Microarrays; Squamous cell carcinoma

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; DNA MICROARRAY; FEMALE; FOLLOW UP; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MALE; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; VALIDATION PROCESS; ALGORITHM; BIOPSY; ENZYME IMMUNOASSAY; GENETICS; HEAD AND NECK TUMOR; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PREDICTION AND FORECASTING;

ADULT; AGED; ALGORITHMS; BIOPSY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 63249107621     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20005     Document Type: Article

References (22)

1. Adelstein DJ, Li Y., Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21:92-98.
2. Osman I., Sherman E., Singh B., et al. Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol 2002; 20: 2980-2987.
3. Yuen PW, Man M., Lam KY, Kwong YL. Clinicopathological significance of p 16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 2002; 55:58-60.
4. Golub TR, Slonim DK, Tamayo P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286:531-537.
5. Perou CM, Sorlie T., Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747-752.
6. Hanna E., Shrieve DC, Ratanatharathorn V., et al. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res 2001; 61:2376-2380.
7. Ghadimi BM, Grade M., Difilippantonio MJ, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 2005; 23:1826-1838.
8. Dumur CI, Nasim S., Best AM, et al. Evaluation of qualitycontrol criteria for microarray gene expression analysis. Clin Chem 2004; 50:1994-2002.
9. Sugita M., Geraci M., Gao B., et al. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res 2002; 62:3971-3979.
10. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5:R80.
11. Irizarry RA, Bolstad BM, Collin F., et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31:e15.
12. Storey JD. A direct approach to false discovery rates. J R Stat Soc B 2002; 64:479-498.
13. Radmacher MD, McShane LM, Simon R. A. paradigm for class prediction using gene expression profiles. J Comput Biol 2002; 9:505-511.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR the 2 (-Delta Delta C (T)) method. Methods 2001; 25:402-408.
15. Dumur CI, Dechsukhum C., Wilkinson DS, Garrett CT, et al. Analytical validation of a real-time reverse transcription-polymerase chain reaction quantitation of different transcripts of the Wilms' tumor suppressor gene (WT1). Anal Biochem 2002; 309:127-136.
16. Scaffidi AK, Petrovic N., Moodley YP, et al. ανβ3 integrin interacts with the transforming growth factor β (TGFβ) type II receptor to potentiate the proliferative effects of TGFβ1 in living human lung fibroblasts. J Biol Chem 2004; 279:37726-37733.
17. Stipp CS, Hemler ME. Transmembrane-4-superfamily proteins CD151 and CD81 associate with alpha 3 beta 1 integrin, and selectively contribute to alpha 3 beta 1-dependent neurite outgrowth. J Cell Sci 2000:113:1871-1882.
18. Ionescu AM, Schwarz EM, Vinson C., et al. PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling. J Biol Chem 2001; 276:11639-11647.
19. Yamada T., Tsuda M., Ohba Y., Kawaguchi H., Totsuka Y., Shindoh M. PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. Biochem Biophys Res Commun 2008; 368:575-581.
20. Shen X., Qian L., Falzon M. PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway. Exp Cell Res 2004; 294: 420-433.
21. Latham VM, Yu EH, Tullio AN, Adelstein RS, Singer RH. A Rho-dependent signaling pathway operating through myosin localizes beta-actin mRNA in fibroblasts. Curr Biol 2001; 11:1010-1016.
22. Force WR, Glass AA, Benedict CA, et al. Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways. J Biol Chem 2000; 275:11121-11129.